<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Type IV collagen immunostaining patterns in Alport syndrome and thin basement membrane nephropathy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Type IV collagen immunostaining patterns in Alport syndrome and thin basement membrane nephropathy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Type IV collagen immunostaining patterns in Alport syndrome and thin basement membrane nephropathy</div><div class="cntnt"><table cellspacing="0"><colgroup width="40%"></colgroup><colgroup span="3" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1">Disease</td> <td class="subtitle1">Alpha-3 chain</td> <td class="subtitle1">Alpha-4 chain</td> <td class="subtitle1">Alpha-5 chain</td> </tr> <tr class="divider_bottom"> <td colspan="4"><strong>Alport syndrome</strong></td> </tr> <tr> <td class="indent1">X-linked inheritance – males</td> <td>Absent*</td> <td>Absent*</td> <td>Absent*</td> </tr> <tr> <td class="indent1">X-linked inheritance – females</td> <td>Patchy*</td> <td>Patchy*</td> <td>Patchy*</td> </tr> <tr> <td class="indent1">Autosomal recessive inheritance</td> <td>Absent*</td> <td>Absent*</td> <td>Absent in GBM, present in basement membranes of Bowman's capsule and the distal tubule*</td> </tr> <tr class="divider_bottom"> <td class="indent1">Autosomal dominant inheritance</td> <td>Present</td> <td>Present</td> <td>Present</td> </tr> <tr> <td><strong>Thin basement membrane nephropathy</strong><sup>¶</sup></td> <td>Present</td> <td>Present</td> <td>Present</td> </tr> </tbody></table></div><div class="graphic_lgnd">Type IV collagen immunostaining is a useful adjunct to routine evaluation of kidney biopsy samples from patients with isolated glomerular hematuria, particularly when a specific diagnosis is not provided by routine immunofluorescence and electron microscopy. Abnormal type IV collagen immunostaining is highly suggestive of Alport syndrome. It is important to note that thin GBMs and normal type IV collagen immunostaining may be observed in patients with hemizygous and heterozygous mutations in <em>COL4A5</em>, heterozygous mutations in <em>COL4A3</em> and <em>COL4A4</em>, and mutations in both alleles of <em>COL4A3</em> and <em>COL4A4</em> and may be associated with progressive renal disease. Except as noted, the present/absent designation in the table refers to GBM staining only.</div><div class="graphic_footnotes">GBM: glomerular basement membrane.<br/>	

	* Up to 20% of male patients and 30 to 40% of female patients with X-linked Alport syndrome may exhibit positive staining for the alpha-3, alpha-4, and alpha-5 chains of type IV collagen. Some patients with autosomal recessive Alport syndrome have normal type IV collagen immunostaining.<br/>	

	¶ Some clinicians (including the authors of the associated topic) consider patients who have thin GBMs and a <em>COL4A3</em> or <em>COL4A4</em> mutation to have autosomal dominant Alport syndrome.</div><div id="graphicVersion">Graphic 118692 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
